Tocilizumab in the treatment of active chronic humoral rejection resistant to standard therapy Betty Chamoun; Pablo Sánchez-Sancho; Irina B. Torres; Alejandra Gabaldon; Manel Perelló; Joana Sellarés; Francesc Moreso; Daniel Serón;